Sign in

Markets

Overview
News
World markets
Treasuries
Currencies
Commodities
Economy

Stocks

Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers

ETFs

Overview
Popular funds
Most active
Gainers
Losers
News

Research

Search
Sectors

Tools

My watchlist
My portfolio
Recent quotes

Articles published by Arcus Biosciences

< Previous 1 2 3 4 5 6 Next >

News headline image

Arcus Outlines 2026 Plans for Casdatifan, its Potential Best-in-Class HIF-2a Inhibitor, and its Inflammation Programs

January 07, 2026

From Arcus Biosciences

Via Business Wire

Tickers RCUS

News headline image

Arcus Biosciences to Participate in the 44th Annual J.P. Morgan Healthcare Conference

December 18, 2025

From Arcus Biosciences

Via Business Wire

Tickers RCUS

News headline image

Arcus Provides Update on Phase 3 STAR-221 Study and Concentrates Its R&D Investment on Casdatifan and Emerging Inflammation and Immunology Portfolio

December 12, 2025

From Arcus Biosciences

Via Business Wire

Tickers RCUS

News headline image

Arcus Biosciences Announces New Employment Inducement Grants

December 09, 2025

From Arcus Biosciences

Via Business Wire

Tickers RCUS

News headline image

Arcus Biosciences to Participate in Two Upcoming Investor Conferences

November 18, 2025

From Arcus Biosciences

Via Business Wire

Tickers RCUS

News headline image

Arcus Biosciences Announces Pricing of $250 Million Public Offering of Common Stock

October 30, 2025

From Arcus Biosciences

Via Business Wire

Tickers RCUS

News headline image

Arcus Biosciences Announces Commencement of Public Offering of Common Stock

October 30, 2025

From Arcus Biosciences

Via Business Wire

Tickers RCUS

News headline image

Arcus Biosciences Reports Third-Quarter 2025 Financial Results and Provides a Pipeline Update

October 28, 2025

From Arcus Biosciences

Via Business Wire

Tickers RCUS

News headline image

Taiho Pharmaceutical Exercises Option for an Exclusive License to Casdatifan in Japan and Certain Territories in Asia

October 19, 2025

From Arcus Biosciences

Via Business Wire

Tickers RCUS

News headline image

Arcus Biosciences Announces New Employment Inducement Grants

October 09, 2025

From Arcus Biosciences

Via Business Wire

Tickers RCUS

News headline image

Arcus Biosciences Presents New Data for its HIF-2a Inhibitor Casdatifan and Discloses First Inflammation Programs at Investor Event

October 06, 2025

From Arcus Biosciences

Via Business Wire

Tickers RCUS

News headline image

Arcus Biosciences Announces New Employment Inducement Grants

September 24, 2025

From Arcus Biosciences

Via Business Wire

Tickers RCUS

News headline image

Arcus Biosciences Announces New Employment Inducement Grants

September 08, 2025

From Arcus Biosciences

Via Business Wire

Tickers RCUS

News headline image

Arcus Biosciences to Host Investor Event to Highlight its Late-Stage Casdatifan Program and Next Wave of Programs Focused on Inflammation

September 02, 2025

From Arcus Biosciences

Via Business Wire

Tickers RCUS

News headline image

Arcus Biosciences to Participate in Three Upcoming Investor Conferences

August 20, 2025

From Arcus Biosciences

Via Business Wire

Tickers RCUS

News headline image

Arcus Biosciences Reports Second-Quarter 2025 Financial Results and Provides a Pipeline Update

August 06, 2025

From Arcus Biosciences

Via Business Wire

Tickers RCUS

News headline image

Arcus Biosciences Announces New Employment Inducement Grants

July 24, 2025

From Arcus Biosciences

Via Business Wire

Tickers RCUS

News headline image

Arcus Biosciences’ Quemliclustat Receives Orphan Drug Designation for Pancreatic Cancer

July 10, 2025

From Arcus Biosciences

Via Business Wire

Tickers RCUS

News headline image

Arcus Biosciences Announces New Employment Inducement Grants

July 09, 2025

From Arcus Biosciences

Via Business Wire

Tickers RCUS

News headline image

Arcus Biosciences Announces New Employment Inducement Grants

June 24, 2025

From Arcus Biosciences

Via Business Wire

Tickers RCUS

News headline image

Arcus Biosciences Announces New Employment Inducement Grants

June 10, 2025

From Arcus Biosciences

Via Business Wire

Tickers RCUS

News headline image

Initial Data from the ARC-20 Study of Casdatifan Plus Cabozantinib Showed Nearly Half of Patients with Metastatic Kidney Cancer Had a Confirmed Response

June 01, 2025

From Arcus Biosciences

Via Business Wire

Tickers RCUS

News headline image

Arcus Biosciences Announces New Employment Inducement Grants

May 27, 2025

From Arcus Biosciences

Via Business Wire

Tickers RCUS

News headline image

Arcus Biosciences Announces New Employment Inducement Grants

May 09, 2025

From Arcus Biosciences

Via Business Wire

Tickers RCUS

News headline image

Arcus Biosciences Reports First-Quarter 2025 Financial Results and Provides a Pipeline Update

May 06, 2025

From Arcus Biosciences

Via Business Wire

Tickers RCUS

News headline image

Arcus Biosciences Announces New Employment Inducement Grants

April 24, 2025

From Arcus Biosciences

Via Business Wire

Tickers RCUS

News headline image

Arcus Biosciences to Present First Combination Data for HIF-2a Inhibitor Casdatifan Plus Cabozantinib in an Oral Presentation at the 2025 ASCO Annual Meeting

April 23, 2025

From Arcus Biosciences

Via Business Wire

Tickers RCUS

News headline image

Arcus Biosciences to Host Conference Call to Discuss First-Quarter 2025 Financial Results and Pipeline Update

April 22, 2025

From Arcus Biosciences

Via Business Wire

Tickers RCUS

News headline image

Arcus Biosciences Announces New Employment Inducement Grants

April 09, 2025

From Arcus Biosciences

Via Business Wire

Tickers RCUS

News headline image

Arcus Biosciences Announces New Employment Inducement Grants

March 25, 2025

From Arcus Biosciences

Via Business Wire

Tickers RCUS

< Previous 1 2 3 4 5 6 Next >

© 2026 FinancialContent Services, Inc. All rights reserved.

Privacy Policy Terms of Service About

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.